UEG Podcast is a specialist series for people working inside digestive health. Its center of gravity is clinical judgment. The show usually begins with a defined problem from gastroenterology practice, then moves into the evidence, the uncertainties, and the next decision a clinician has to make. Recent IBD coverage looks at malignancy risk in complex treatment situations, including the safety record of vedolizumab, ustekinumab, newer related agents, and JAK inhibitors. The discussion is careful about signal, duration of use, registry evidence, and the limits of comparing patient groups across specialties. Coeliac disease receives the same practical treatment. Episodes distinguish potential and definite coeliac disease, explain why isolated findings can mislead, and return to the everyday work of gluten challenge, histology, serology, dietetic support, and patient expectations. Endoscopy episodes shift between history and access. The series treats fiber optic endoscopy as a major turning point, while also asking what care looks like in rural or under-resourced settings where GI bleeding, cholangitis, and cancer may present without timely intervention. A colonoscopy roundtable adds a more procedural texture, with quality metrics, ADR improvement, serrated lesions, surveillance intervals, optical diagnosis, artificial intelligence, and case-based decision-making. The cancer-focused episodes are equally precise. Immunotherapy is discussed across the spectrum of GI tumors, from more immune-sensitive cancers to microsatellite-stable colorectal cancer and pancreatic cancer, where current options remain limited. Pancreatic cystic neoplasm coverage stays close to guideline construction, observational bias, diagnostic error, surgical series, and the uncomfortable fact that short follow-up may not answer long-risk questions. The result is a show that respects expertise without turning it into performance. It is calm, technical, and useful, especially when the answer is not clean.